Syndax Pharmaceuticals Inc (SNDX)
Free Cash Flow
-$30.31M
Quarterly · Period ending: · USD
SNDX Free Cash Flow
Latest reported-$30.31Mperiod ending
Latest reported-$30.31Mperiod ending
SNDX Quarterly Free Cash Flow (-$1.07K → -$30.31M)
Quarterly free cash flow
High-resolution chart · PNG
SNDX free cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Free Cash Flow (USD) |
|---|---|
| -30,312,000 | |
| -50,345,000 | |
| -69,544,000 | |
| -70,666,000 | |
| -87,795,000 | |
| -95,162,000 | |
| -57,388,000 | |
| -62,322,000 | |
| -71,645,000 | |
| -83,548,000 | |
| -41,349,000 | |
| -44,653,000 | |
| -35,371,000 | |
| -39,228,000 | |
| -22,894,000 | |
| -28,544,000 | |
| -40,306,000 | |
| -41,931,000 | |
| 100,580,000 | |
| -24,944,000 | |
| -24,045,000 | |
| -22,589,000 | |
| -15,631,000 | |
| -18,297,000 | |
| -21,407,000 | |
| -15,925,000 | |
| -12,727,000 | |
| -8,529,000 | |
| -12,525,000 | |
| -16,831,000 | |
| -15,057,000 | |
| -18,469,000 | |
| -15,149,000 | |
| -20,043,000 | |
| -12,764,000 | |
| -10,223,000 | |
| -11,800,000 | |
| -12,668,000 | |
| -10,416,000 | |
| -11,503,000 | |
| -6,963,000 | |
| -6,536,000 | |
| -4,326,000 | |
| -5,195,000 | |
| -4,001,000 | |
| 11,045,000 | |
| -3,479,000 | |
| -2,602,000 | |
| -3,804,000 | |
| -4,512,000 | |
| -2,786,000 | |
| -2,135,000 | |
| -927,000 | |
| -1,485,000 | |
| -1,065 |